In experiments with noncompliance, some subjects assigned to the treatment group may be unlikely to actually receive treatment, presenting difficulties for obtaining precise estimates of treatment effects. In this study, we seek to address the issue by introducing a class of compliance-weighted Wald estimators in which those unlikely to be compliers are downweighted and observe the effects.

Why we believe Shelby can operate at prices that are competitive with existing Web2 providers, like AWS and GCP.
Why we believe Shelby can operate at prices that are competitive with existing Web2 providers, like AWS and GCP.
Arguably the greatest breakthrough of blockchains and cryptocurrencies is that they have unlocked a fundamentally new way for humans to organize.
Arguably the greatest breakthrough of blockchains and cryptocurrencies is that they have unlocked a fundamentally new way for humans to organize.